OR WAIT null SECS
February 02, 2024
The industry’s M&A activity is on the up and expected to continue to rise in 2024.
January 02, 2024
Clarivate has released its 2024 Drugs to Watch report, highlighting 13 therapies with great potential.
December 02, 2023
Drug shortages across Europe are being exacerbated by increased demand, struggling supply chains, and manufacturer suspensions.
October 24, 2023
The report indicates a rise in biotech funding and subsequent growth for pharma contract services.
September 02, 2023
European vaccine manufacturing is being boosted with high level investments.
August 02, 2023
Only a significant joint effort across the supply chain will help to make healthcare more sustainable and reduce the impact of climate change on global health.
July 13, 2023
Start-ups are plagued with common issues that dramatically decrease their odds of achieving investor funding.
July 02, 2023
The UK and EU have negotiated a new draft deal for Britain to re-join the Horizon Europe research programme.
The debate surrounding drug pricing changes rages on.
June 08, 2023
BIO is a powerful business development conference that can help make a lot of deals become reality.